- Home
- MRNA vs UHS Comparison
MRNA vs UHS Comparison
Compare MRNA & UHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- UHS
- Stock Information
- Founded
- MRNA 2010
- UHS 1978
- Country
- MRNA United States
- UHS United States
- Employees
- MRNA N/A
- UHS N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- UHS Hospital/Nursing Management
- Sector
- MRNA Health Care
- UHS Health Care
- Exchange
- MRNA Nasdaq
- UHS Nasdaq
- Market Cap
- MRNA 9.8B
- UHS 10.9B
- IPO Year
- MRNA 2018
- UHS N/A
- Fundamental
- Price
- MRNA $27.89
- UHS $205.19
- Analyst Decision
- MRNA Hold
- UHS Hold
- Analyst Count
- MRNA 17
- UHS 14
- Target Price
- MRNA $42.40
- UHS $216.77
- AVG Volume (30 Days)
- MRNA 12.3M
- UHS 652.0K
- Earning Date
- MRNA 11-06-2025
- UHS 10-23-2025
- Dividend Yield
- MRNA N/A
- UHS 0.39%
- EPS Growth
- MRNA N/A
- UHS 39.27
- EPS
- MRNA N/A
- UHS 18.95
- Revenue
- MRNA $3,078,000,000.00
- UHS $16,460,285,000.00
- Revenue This Year
- MRNA N/A
- UHS $9.67
- Revenue Next Year
- MRNA $9.75
- UHS $4.93
- P/E Ratio
- MRNA N/A
- UHS $10.84
- Revenue Growth
- MRNA N/A
- UHS 9.61
- 52 Week Low
- MRNA $23.15
- UHS $152.33
- 52 Week High
- MRNA $59.73
- UHS $240.26
- Technical
- Relative Strength Index (RSI)
- MRNA 58.77
- UHS 74.60
- Support Level
- MRNA $26.91
- UHS $200.90
- Resistance Level
- MRNA $28.99
- UHS $212.87
- Average True Range (ATR)
- MRNA 1.22
- UHS 4.23
- MACD
- MRNA 0.35
- UHS 0.72
- Stochastic Oscillator
- MRNA 76.78
- UHS 83.37
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About UHS Universal Health Services Inc.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.